Archives
-
Angiotensin III: From Peptide to Assay Signal
2026-08-27
Angiotensin III is more than a shorter angiotensin II metabolite: its sequence, receptor profile, and endpoint-specific activity make it a powerful control for RAAS experiments. This guide connects peptide chemistry with assay design and interprets emerging spike-binding evidence without overstating translational conclusions.
-
Genistein for Reproducible Cell Assays
2026-08-27
This scenario-driven guide explains how Genistein (SKU A2198) can support more interpretable cell proliferation, viability, cytotoxicity, and mechanotransduction experiments. It connects concentration selection, solvent handling, orthogonal readouts, and vendor evaluation to published and product-documented evidence.
-
Nanoplastic–Cadmium Apoptosis via IP3R/Ca2+/STAT3
2026-08-26
The reference study shows that polystyrene nanoplastics and cadmium produce combined intestinal toxicity in both C. elegans and Caco-2 cells, with apoptosis associated with the IP3R/Ca2+/STAT3 pathway. Pharmacological inhibition of IP3R, calcium chelation with BAPTA, or STAT3 phosphorylation reduced the response, providing a useful mechanistic framework for environmental toxicology and calcium-focused cell assays.
-
Sulfo-NHS-LC-Biotin: Practical Labeling Guide
2026-08-26
Sulfo-NHS-LC-Biotin provides water-compatible, irreversible biotin labeling of primary amines on proteins, peptides, and intact-cell surface proteins. It is suited to stable extracellular labeling and streptavidin-based capture or detection, but not to intracellular or reversible biotinylation workflows.
-
Cy3-UTP for Fluorescent RNA Labeling
2026-08-25
Cy3-UTP is a Cy3-modified uridine triphosphate for in vitro transcription RNA labeling. Its reported water solubility, fluorescence, and cold-storage requirements support controlled generation of labeled RNA for imaging, RNA-protein interaction studies, and RNA detection assays.
-
Ozone, Efferocytosis, and Neuropathic Pain
2026-08-25
A 2024 Frontiers in Immunology study identifies macrophage efferocytosis as a modifiable component of neuropathic pain and links ozone treatment to the AMPK/Gas6-MerTK/SOCS3 pathway. In chronic constriction injury mice and macrophage cultures, the intervention improved apoptotic-cell clearance, reduced inflammatory signaling, and alleviated mechanical hypersensitivity, while pathway inhibitors weakened these effects.
-
GDC-0068 Workflows for Akt Research
2026-08-24
GDC-0068 (RG7440) combines nanomolar pan-AKT potency with a practical workflow for linking pathway inhibition to proliferation, cell-cycle, and survival phenotypes. Its greatest value emerges when genotype-aware dosing, phospho-signaling time courses, and spatially resolved mTORC1 assays are interpreted together rather than relying on viability data alone.
-
3D Proteomics and Carboplatin Response in HGSOC
2026-08-24
A 2025 Journal of Proteome Research study compared whole-cell proteomes from four high-grade serous ovarian carcinoma models grown in 2D monolayers and 3D spheroids. Its findings show that culture dimensionality reshapes metabolism, membrane-protein abundance, and carboplatin-associated resistance signatures, supporting more physiologically relevant models for preclinical oncology research.
-
Glutaraldehyde Genetic Toxicology: Methods and Findings
2026-08-23
Vergnes and Ballantyne evaluated glutaraldehyde with a coordinated battery of bacterial, mammalian-cell, and animal genotoxicity assays. The study found a weak, metabolism-dependent bacterial response but no reproducible mammalian-cell mutation or clastogenicity and no evidence of in vivo chromosome damage, illustrating why genetic toxicology conclusions require multiple complementary endpoints.
-
Phellodendrine Chloride in Gouty Arthritis
2026-08-22
The 2025 Immunobiology study identifies phellodendrine chloride as a potential modulator of gout-associated inflammation and cartilage matrix loss. Using animal and chondrocyte models, the researchers connect reduced MMP-3 expression and proteoglycan preservation with altered IL-6/STAT3 signaling, while also defining important limits for translation.
-
Cy3-UTP for Mechanistic RNA Assays
2026-08-22
Cy3-UTP enables bright, photostable RNA labeling for mechanistic assays rather than simple visualization alone. This guide explains how to interpret labeled RNA in protein-binding, imaging, and nanoparticle-delivery experiments while connecting assay design to recent RNA nanocarrier research.
-
Antibacterial Use and Resistance in Psychiatric Hospitals
2026-08-21
This retrospective study links antibacterial utilization with bacterial resistance patterns in a psychiatric hospital during the 2022 epidemic, while benchmarking local practice against Jiangsu Province and national data. Its main contribution is an integrated stewardship framework combining drug-use indicators, microbiological submission, pathogen identification, and susceptibility testing.
-
Gamma-Linolenic Acid: From Signal to Assay
2026-08-20
Gamma-linolenic acid (GLA) is more than an anti-inflammatory reagent: it is a way to connect receptor binding, cell viability, and translational immune readouts. This assay-first guide clarifies what GLA evidence shows—and what recent arachidonic acid research does not yet prove.
-
2X Taq PCR Master Mix for CRC Genotyping
2026-08-20
Use 2X Taq PCR Master Mix (with dye) to simplify endpoint PCR for NEIL1-related genotyping, COL17A1 assay development, gel verification, and TA cloning. Its premixed chemistry reduces setup errors, while integrated loading dye enables direct agarose-gel loading after amplification.
-
Betaine Hydrochloride in Translational Enzyme Research
2026-08-19
A mechanism-aware guide to using betaine hydrochloride in metabolic enzyme, protease, cell culture, and molecular biology workflows, with translational lessons from inflammation-driven esophageal cancer research.